Equities Analysts Issue Forecasts for ALLO Q1 Earnings
William Blair issued their Q1 2026 EPS estimates for shares of Allogene Therapeutics in a note issued to investors on Friday, March 14th. William Blair analyst S. Corwin expects that the company will ...
UBS Group Increases Futu (NASDAQ:FUTU) Price Target to $136.00
Futu (NASDAQ:FUTU – Free Report) had its target price hoisted by UBS Group from $130.00 to $136.00 in a research report sent ...